A citation-based method for searching scientific literature

Markus J Riemenschneider, Arie Perry, Guido Reifenberger. Lancet Neurol 2006
Times Cited: 324







List of co-cited articles
584 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
39

Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.
Victoria E Clark, E Zeynep Erson-Omay, Akdes Serin, Jun Yin, Justin Cotney, Koray Ozduman, Timuçin Avşar, Jie Li, Phillip B Murray, Octavian Henegariu,[...]. Science 2013
486
23

Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.
Priscilla K Brastianos, Peleg M Horowitz, Sandro Santagata, Robert T Jones, Aaron McKenna, Gad Getz, Keith L Ligon, Emanuele Palescandolo, Paul Van Hummelen, Matthew D Ducar,[...]. Nat Genet 2013
377
20

EANO guidelines for the diagnosis and treatment of meningiomas.
Roland Goldbrunner, Giuseppe Minniti, Matthias Preusser, Michael D Jenkinson, Kita Sallabanda, Emmanuel Houdart, Andreas von Deimling, Pantelis Stavrinou, Florence Lefranc, Morten Lund-Johansen,[...]. Lancet Oncol 2016
377
20

The 2007 WHO classification of tumours of the central nervous system.
David N Louis, Hiroko Ohgaki, Otmar D Wiestler, Webster K Cavenee, Peter C Burger, Anne Jouvet, Bernd W Scheithauer, Paul Kleihues. Acta Neuropathol 2007
18

Epidemiology and etiology of meningioma.
Joseph Wiemels, Margaret Wrensch, Elizabeth B Claus. J Neurooncol 2010
585
17

Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review.
Leland Rogers, Igor Barani, Marc Chamberlain, Thomas J Kaley, Michael McDermott, Jeffrey Raizer, David Schiff, Damien C Weber, Patrick Y Wen, Michael A Vogelbaum. J Neurosurg 2015
304
15

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Felix Sahm, Daniel Schrimpf, Damian Stichel, David T W Jones, Thomas Hielscher, Sebastian Schefzyk, Konstantin Okonechnikov, Christian Koelsche, David E Reuss, David Capper,[...]. Lancet Oncol 2017
330
14


Pathological classification and molecular genetics of meningiomas.
Christian Mawrin, Arie Perry. J Neurooncol 2010
266
13

The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments.
Winward Choy, Won Kim, Daniel Nagasawa, Stephanie Stramotas, Andrew Yew, Quinton Gopen, Andrew T Parsa, Isaac Yang. Neurosurg Focus 2011
120
12

Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas.
Victoria E Clark, Akdes Serin Harmancı, Hanwen Bai, Mark W Youngblood, Tong Ihn Lee, Jacob F Baranoski, A Gulhan Ercan-Sencicek, Brian J Abraham, Abraham S Weintraub, Denes Hnisz,[...]. Nat Genet 2016
171
11

Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma.
Malak Abedalthagafi, Wenya Linda Bi, Ayal A Aizer, Parker H Merrill, Ryan Brewster, Pankaj K Agarwalla, Marc L Listewnik, Dora Dias-Santagata, Aaron R Thorner, Paul Van Hummelen,[...]. Neuro Oncol 2016
148
11

TERT Promoter Mutations and Risk of Recurrence in Meningioma.
Felix Sahm, Daniel Schrimpf, Adriana Olar, Christian Koelsche, David Reuss, Juliane Bissel, Annekathrin Kratz, David Capper, Sebastian Schefzyk, Thomas Hielscher,[...]. J Natl Cancer Inst 2015
188
11

Meningiomas.
Ian R Whittle, Colin Smith, Parthiban Navoo, Donald Collie. Lancet 2004
389
10

Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes.
M Kalamarides, A O Stemmer-Rachamimov, M Niwa-Kawakita, F Chareyre, E Taranchon, Z-Y Han, C Martinelli, E A Lusis, B Hegedus, D H Gutmann,[...]. Oncogene 2011
93
10

WHO grade II and III meningiomas: a study of prognostic factors.
Anne Durand, François Labrousse, Anne Jouvet, Luc Bauchet, Michel Kalamaridès, Philippe Menei, Robert Deruty, Jean Jacques Moreau, Michelle Fèvre-Montange, Jacques Guyotat. J Neurooncol 2009
202
9

Genomic landscape of high-grade meningiomas.
Wenya Linda Bi, Noah F Greenwald, Malak Abedalthagafi, Jeremiah Wala, Will J Gibson, Pankaj K Agarwalla, Peleg Horowitz, Steven E Schumacher, Ekaterina Esaulova, Yu Mei,[...]. NPJ Genom Med 2017
85
10

Advances in meningioma genetics: novel therapeutic opportunities.
Matthias Preusser, Priscilla K Brastianos, Christian Mawrin. Nat Rev Neurol 2018
78
11

An overview of meningiomas.
Robin A Buerki, Craig M Horbinski, Timothy Kruser, Peleg M Horowitz, Charles David James, Rimas V Lukas. Future Oncol 2018
117
9

Genetic landscape of meningioma.
Sayaka Yuzawa, Hiroshi Nishihara, Shinya Tanaka. Brain Tumor Pathol 2016
66
12

Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations.
David E Reuss, Rosario M Piro, David T W Jones, Matthias Simon, Ralf Ketter, Marcel Kool, Albert Becker, Felix Sahm, Stefan Pusch, Jochen Meyer,[...]. Acta Neuropathol 2013
146
8

Relationship between tumor location, size, and WHO grade in meningioma.
Stephen T Magill, Jacob S Young, Ricky Chae, Manish K Aghi, Philip V Theodosopoulos, Michael W McDermott. Neurosurg Focus 2018
47
17

Current treatment options for meningioma.
Caroline Apra, Matthieu Peyre, Michel Kalamarides. Expert Rev Neurother 2018
69
11

Integrated genomic analyses of de novo pathways underlying atypical meningiomas.
Akdes Serin Harmancı, Mark W Youngblood, Victoria E Clark, Süleyman Coşkun, Octavian Henegariu, Daniel Duran, E Zeynep Erson-Omay, Leon D Kaulen, Tong Ihn Lee, Brian J Abraham,[...]. Nat Commun 2017
91
8

Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
S-Y Yang, C-K Park, S-H Park, D G Kim, Y S Chung, H-W Jung. J Neurol Neurosurg Psychiatry 2008
182
8

Radiosurgery as definitive management of intracranial meningiomas.
Douglas Kondziolka, David Mathieu, L Dade Lunsford, Juan J Martin, Ricky Madhok, Ajay Niranjan, John C Flickinger. Neurosurgery 2008
259
7


High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression.
Stéphane Goutagny, Jean C Nault, Maxime Mallet, Dominique Henin, Jessica Z Rossi, Michel Kalamarides. Brain Pathol 2014
158
7

"Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications.
A Perry, B W Scheithauer, S L Stafford, C M Lohse, P C Wollan. Cancer 1999
434
7

Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.
Manish K Aghi, Bob S Carter, Garth R Cosgrove, Robert G Ojemann, Sepideh Amin-Hanjani, Robert L Martuza, William T Curry, Fred G Barker. Neurosurgery 2009
302
7

Role of Merlin/NF2 inactivation in tumor biology.
A M Petrilli, C Fernández-Valle. Oncogene 2016
173
7

Extent of resection and overall survival for patients with atypical and malignant meningioma.
Ayal A Aizer, Wenya Linda Bi, Manjinder S Kandola, Eudocia Q Lee, Lakshmi Nayak, Mikael L Rinne, Andrew D Norden, Rameen Beroukhim, David A Reardon, Patrick Y Wen,[...]. Cancer 2015
94
7

Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.
Adriana Olar, Khalida M Wani, Erik P Sulman, Alireza Mansouri, Gelareh Zadeh, Charmaine D Wilson, Franco DeMonte, Gregory N Fuller, Kenneth D Aldape. Brain Pathol 2015
75
8

The role of adjuvant radiotherapy in atypical meningioma.
Hae Jin Park, Hyun-Cheol Kang, Il Han Kim, Sung-Hye Park, Dong Gyu Kim, Chul-Kee Park, Sun Ha Paek, Hee-Won Jung. J Neurooncol 2013
86
6

Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy.
T W Dziuk, S Woo, E B Butler, J Thornby, R Grossman, W S Dennis, H Lu, L S Carpenter, J K Chiu. J Neurooncol 1998
190
6

The ROAM/EORTC-1308 trial: Radiation versus Observation following surgical resection of Atypical Meningioma: study protocol for a randomised controlled trial.
Michael D Jenkinson, Mohsen Javadpour, Brian J Haylock, Bridget Young, Helen Gillard, Jacqui Vinten, Helen Bulbeck, Kumar Das, Michael Farrell, Seamus Looby,[...]. Trials 2015
107
6

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013.
Quinn T Ostrom, Haley Gittleman, Jordan Xu, Courtney Kromer, Yingli Wolinsky, Carol Kruchko, Jill S Barnholtz-Sloan. Neuro Oncol 2016
663
6

The histopathological spectrum of human meningiomas.
Thomas Backer-Grøndahl, Bjørnar H Moen, Sverre H Torp. Int J Clin Exp Pathol 2012
112
6

Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas.
M H Ruttledge, J Sarrazin, S Rangaratnam, C M Phelan, E Twist, P Merel, O Delattre, G Thomas, M Nordenskjöld, V P Collins. Nat Genet 1994
443
6

A review of epigenetic and gene expression alterations associated with intracranial meningiomas.
Shuhan He, Martin H Pham, Matthew Pease, Gabriel Zada, Steven L Giannotta, Kai Wang, William J Mack. Neurosurg Focus 2013
38
15

Surgery for convexity meningioma: Simpson Grade I resection as the goal: clinical article.
Bernt Filip Hasseleid, Torstein R Meling, Pål Rønning, David Scheie, Eirik Helseth. J Neurosurg 2012
115
6

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.
Quinn T Ostrom, Haley Gittleman, Jordonna Fulop, Max Liu, Rachel Blanda, Courtney Kromer, Yingli Wolinsky, Carol Kruchko, Jill S Barnholtz-Sloan. Neuro Oncol 2015
6

Impaired survival and long-term neurological problems in benign meningioma.
Hanna van Alkemade, Michelle de Leau, Edith M T Dieleman, Jan W P F Kardaun, Rob van Os, W Peter Vandertop, Wouter R van Furth, Lukas J A Stalpers. Neuro Oncol 2012
147
6

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.
Quinn T Ostrom, Gino Cioffi, Haley Gittleman, Nirav Patil, Kristin Waite, Carol Kruchko, Jill S Barnholtz-Sloan. Neuro Oncol 2019
894
6

DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management.
Farshad Nassiri, Yasin Mamatjan, Suganth Suppiah, Jetan H Badhiwala, Sheila Mansouri, Shirin Karimi, Olli Saarela, Laila Poisson, Irina Gepfner-Tuma, Jens Schittenhelm,[...]. Neuro Oncol 2019
83
7

Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042).
Damien C Weber, Carmen Ares, Salvador Villa, Saskia M Peerdeman, Laurette Renard, Brigitta G Baumert, Anna Lucas, Theo Veninga, Alessia Pica, Sarah Jefferies,[...]. Radiother Oncol 2018
70
8

Anatomic location is a risk factor for atypical and malignant meningiomas.
Ari J Kane, Michael E Sughrue, Martin J Rutkowski, Gopal Shangari, Shanna Fang, Michael W McDermott, Mitchel S Berger, Andrew T Parsa. Cancer 2011
116
5

Meningioma.
Christine Marosi, Marco Hassler, Karl Roessler, Michele Reni, Milena Sant, Elena Mazza, Charles Vecht. Crit Rev Oncol Hematol 2008
209
5

Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings.
Ossama Al-Mefty, Paulo A S Kadri, Svetlana Pravdenkova, Jeffrey R Sawyer, Colin Stangeby, Muhammad Husain. J Neurosurg 2004
150
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.